Literature DB >> 7098542

Isolation and preliminary characterisation of mycoplasmavirus 20-P.

E Jansson, A Backman, K Hakkarainen, C H von Bonsdorff, B Seniusová, A Miettinen.   

Abstract

A mycoplasmavirus, MV 20-P, was isolated from the fastidious, slow-growing human mycoplasma 20-P, previously identified by the growth inhibition test as Mycoplasma hominis type 2. Its broth culture was ultracentrifuged into 35% saccharose, the pellet was resuspensed in buffer, and the suspension was dropped onto laws of the virus indicator Acholeplasma laidlawii BCL-13. The virus was washed off the plaque areas by buffer. MV 20-P appeared in electron microscopy as spherical, enveloped particles about 80 nm in diameter. It was sensitive to lipid solvents. These preliminary results indicate that MV 20-P is a MVL2 type mycoplasmavirus and possibly the first of human origin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7098542

Source DB:  PubMed          Journal:  Med Biol        ISSN: 0302-2137


  4 in total

Review 1.  Mycoplasmas and arthritis.

Authors:  K Hakkarainen; H Turunen; A Miettinen; M Karppelin; K Kaitila; E Jansson
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

2.  Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection.

Authors:  Matthew Josiah Allen-Daniels; Myrna G Serrano; Lindsey P Pflugner; Jennifer M Fettweis; Melissa A Prestosa; Vishal N Koparde; J Paul Brooks; Jerome F Strauss; Roberto Romero; Tinnakorn Chaiworapongsa; David A Eschenbach; Gregory A Buck; Kimberly K Jefferson
Journal:  Am J Obstet Gynecol       Date:  2015-01-28       Impact factor: 8.661

Review 3.  Molecular biology and genetics of mycoplasmas (Mollicutes).

Authors:  S Razin
Journal:  Microbiol Rev       Date:  1985-12

4.  Acholeplasma laidlawii retains sensitivity to exogenous virus while releasing endogenous, mitomycin C induced, virus. Brief report.

Authors:  A Liss; K Hakkarainen; E Jansson
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.